ACCURNA
AccRna, Inc.'s aim is to promote therapeutic innovation in the form of nucleic acid medicine utilizing our robust DDS platform, providing effective treatment for refractory diseases for which there is currently no cure. Our dream is to deliver a โradical cureโ to patients suffering from refractory diseases all over the world by safely and efficiently achieving the ultimate in the therapy utilizing nucleic acid.
ACCURNA
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2015-12-01
Address:
Hongo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.accurna.com
Total Employee:
11+
Status:
Active
Contact:
+81-3-5803-2862
Email Addresses:
[email protected]
Total Funding:
770.25 M JPY
Technology used in webpage:
Google Maps Japanese Server Location
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Advisors List
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-09-30 | NanoCarrier Co | NanoCarrier Co acquired by AccuRna | N/A |
Investors List
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. investment in Series B - AccuRna
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Series B - AccuRna
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. investment in Series B - AccuRna
SMBC Venture Capital
SMBC Venture Capital investment in Series B - AccuRna
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Series B - AccuRna
NanoCarrier Co
NanoCarrier Co investment in Series B - AccuRna
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. investment in Seed Round - AccuRna
Official Site Inspections
http://www.accurna.com
- Host name: www9.gmoserver.jp
- IP address: 160.251.229.1
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "AccuRna"
AccuRna, Inc.
Jul 27, 2020ย ยท AccuRna is a Japanese biotech startup dedicated to nucleic acid therapeutics especially focusing on unique drug delivery platformsSee details»
About us โ AccuRna, Inc.
AccuRna was founded in 2015 to implement research results in academia socially. Our dream is to deliver a โradical cureโ to patients suffering from refractory diseases all over the world by โฆSee details»
Management team โ AccuRna, Inc.
Dr. Akinaga joined Kyowa Hakko Kogyo Co., Ltd, where he engaged in exploration and evaluation of anti-cancer drugs at pharmaceutical research center for 20 years and worked on many anti โฆSee details»
AccuRna - Crunchbase Company Profile & Funding
AccuRna is pioneering unique drug delivery system (DDS) for nucleic acid therapeutics, both of short chain and long chain. AccRna, Inc.'s aim is to promote therapeutic innovation in the form โฆSee details»
AccuRna Company Profile 2024: Valuation, Investors, Acquisition
AccuRna was founded in 2015. Where is AccuRna headquartered? AccuRna is headquartered in Bunkyo-ku, Japan. What is the size of AccuRna? AccuRna has 23 total employees. What โฆSee details»
AccuRna - Contacts, Employees, Board Members, Advisors & Alumni
AccuRna is pioneering unique drug delivery system (DDS) for nucleic acid therapeutics, both of short chain and long chain.See details»
AccuRna - Funding, Financials, Valuation & Investors - Crunchbase
AccuRna is pioneering unique drug delivery system (DDS) for nucleic acid therapeutics, both of short chain and long chain.See details»
AccuRna Company Profile - Office Locations, Competitors ... - Craft
AccuRna (ๆ ชๅผไผ็คพใขใญใฅใซใ) is a company developing a drug delivery system (DDS) for nucleic acid therapeutics, both of short chain including ASO, siRNA, miRNA and long chain, โฆSee details»
AccuRna - Overview, News & Similar companies | ZoomInfo.com
Mar 6, 2018ย ยท View AccuRna (www.accurna.com) location in Tokyo, Japan , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Corporate Overview - accurna.com
AccuRna Inc. 8 uPIC stabilizes nucleic acid therapeutics in mice body thus achieving improved retention in blood, accumulation into a tumor and greater antitumor effectsSee details»
AccuRna - Products, Competitors, Financials, Employees, โฆ
AccuRna is a biotech company specializing in nucleic acid therapeutics with a focus on drug delivery systems. Use the CB Insights Platform to explore AccuRna's full profile.See details»
AccuRna, Inc. - VentureRadar
Website: https://www.accurna.com/en. Associated sectors: Drug Delivery/Formulation; Similar Companies: Phion Therapeutics United Kingdom Privately Held pHion Therapeutics Ltd. is โฆSee details»
AccuRna - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 1, 2024ย ยท AccuRna is ranked 15,928,599 among websites globally based on its 46 monthly web visitors. AccuRna is pioneering unique drug delivery system (DDS) for nucleic acid โฆSee details»
Corporate Overview EN blue 20181210 - AccuRna
1ryho ''6 whfkqrorj\ xqlw 3ro\ ,rq &rpsoh[ x3,& x3,& lv d vlpsoh vroxwlrq iru ''6 ri vkruw fkdlq qxfohlf dflg wkhudshxwlfv dv vl51$ $62 dqgSee details»
Webinar Series on Frontier of mRNA Drug Discovery - CMIC Group
Tokyo- August 26, 2020 โ CMIC HOLDINGS Co., Ltd. (CMIC) and AccuRna Inc. (AccuRna) jointly held a series of webinars on messenger RNA (mRNA) medicines, Frontier of mRNA Drug โฆSee details»
AccuRNA Inc. - BioCentury Company Profiles - BCIQ
AccuRNA Inc. - BioCentury Company Profiles for the biopharma industry. AccuRNA Inc. - BioCentury Company Profiles for the biopharma industry. LOG IN. Analysis. Featured โฆSee details»
AccuRna, Inc. Secures JPY 520 Million in Financing.
Jan 17, 2018ย ยท AccuRna, Inc. (headquartered in Hongo, Bunkyo-ku, Japan, CEO: Keiko Hattori, hereinafter AccuRna) today announced it has raised an around JPY 520 million financing, in โฆSee details»
AccuRna - Crunchbase
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients. AccuRna is pioneering unique drug delivery system (DDS) for nucleic acid โฆSee details»
Canadian abortion pill non-profit sees U.S. demand surge | CTV โฆ
1 day agoย ยท A Canadian non-profit that helps women obtain the abortion pill in countries with restrictions says it saw a fourfold increase in U.S. requests after the presidential election.See details»
Technologies โ AccuRna, Inc.
AccuRna DDS provides simple but robust solution to those technical challenges for effective treatment of refractory diseases.See details»